A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers

NCT05753878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: HH-120 nasal spray, PartA cohort 1
DRUG: HH-120 nasal spray, Part A cohort 2-7
DRUG: HH-120 nasal spray, Part A cohort 8-9
DRUG: HH-120 nasal spray, Part B
OTHER: Placebo nasal spray, Part B

Sponsor

Huahui Health